MCT Bioseparation Aps: Financial statements 2022
CVR: 41269774
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MCT Bioseparation Aps (CVR 41269774) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 519,207 and a net result of DKK -56,068 compared with DKK -14,874 the year before. The profit margin was -10.8%. Equity in the 2022 report amounted to DKK -38,669.
- Revenue
- DKK 519,207
- Gross Profit
- DKK 483,874
- Profit/Loss
- DKK -56,068
- Equity
- DKK -38,669
- Total Assets
- DKK 43,669
Official annual report
Keep an eye on MCT Bioseparation Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MCT Bioseparation Aps has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -14,874.
About MCT Bioseparation Aps
MCT Bioseparation Aps is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Meyer Chroma Technology ApS. The management consists of Jørgen Vonsild Skjøde. The company's owners include John Bagterp Jørgensen, Jørgen Vonsild Skjøde and Jacob Skjøde. The company has 1 employee (2025). In 2025, the company reported revenue of DKK 138,591 and a net result of DKK -42 compared with DKK 38,425 the year before. Equity in the 2025 report amounted to DKK 49,958.